Inventor · San Diego, CA, US

Ryan C. Clark

18Patents
4h-index
20Co-inventors
56Inventor score

Filing activity: Sep 29, 2010 → Dec 20, 2019

Most-cited inventions

PatentTitleAreaCited byStatus
US9969710B2 Heteroaryl compounds as IRAK inhibitors and uses thereof Emerging Cross-Sectional Technologies 32 Active
US8664220B2 Polycyclic compounds as lysophosphatidic acid receptor antagonists Chemistry; Metallurgy 15 Active
US8778983B2 Polycyclic compounds as lysophosphatidic acid receptor antagonists Chemistry; Metallurgy 6 Active
US9090573B2 Compounds as lysophosphatidic acid receptor antagonists Chemistry; Metallurgy 5 Active
US9676754B2 Triazolone compounds and uses thereof Chemistry; Metallurgy 2 Active
US9505728B2 Triazolone compounds and uses thereof Chemistry; Metallurgy 2 Active
US9765050B2 Pyridyl reverse sulfonamides for HBV treatment Chemistry; Metallurgy 1 Active
US10160742B2 Pyridyl reverse sulfonamides for HBV treatment Chemistry; Metallurgy 1 Active
US10568871B2 Triazolone compounds and uses thereof Chemistry; Metallurgy 1 Active
US10196351B2 Sulfide alkyl compounds for HBV treatment Chemistry; Metallurgy 1 Active
US10000456B2 Polycyclic compounds as lysophosphatidic acid receptor antagonists Chemistry; Metallurgy 1 Active
US9597332B2 Sulfide alkyl compounds for HBV treatment Chemistry; Metallurgy 1 Active
US10059701B2 Heteroaryl compounds as IRAK inhibitors and uses thereof Chemistry; Metallurgy 0 Active
US10710959B2 Sulfide alkyl compounds for HBV treatment Chemistry; Metallurgy 0 Active
US9624182B2 Compounds as lysophosphatidic acid receptor antagonists Chemistry; Metallurgy 0 Active
US11666557B2 Triazolone compounds and uses thereof Chemistry; Metallurgy 0 Active
US10392375B2 Heteroaryl compounds as IRAK inhibitors and uses thereof Chemistry; Metallurgy 0 Active
US10428041B2 Pyridyl reverse sulfonamides for HBV treatment Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.